Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
Guardado en:
Autores principales: | Aline Lissa Okita, Tatiane Benini, Denise Reis Longhi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Mattioli1885
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/985fde7fec8c4cf2bc426b7226432f67 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Secukinumab in the treatment of psoriasis: patient selection and perspectives
por: Yang EJ, et al.
Publicado: (2018) -
A Rare Infectious Complication of a Treatment with Biologics: Disseminated Cutaneous Leishmaniasis Associated with Adalimumab
por: Kerasia-Maria Plachouri, et al.
Publicado: (2020) -
Clinical evidence of therapy for genital psoriasis by biologic agents
por: Evgeny V. Sokolovskiy, et al.
Publicado: (2021) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018) -
Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis
por: Anzengruber F, et al.
Publicado: (2018)